Aether Industries began with an R&D unit in 2013, and commenced business manufacturing in 2017. It caters to the pharmaceutical, agrochemical, materials science, digital chemical, excessive efficiency images and oil and gasoline trade segments.
Presently, it has a capability of over 4,000 MT.
The Surat-based firm has just lately raised over Rs 100 crore from White Oak Capital and IIFL within the pre-IPO spherical.
The corporate’s working income grew to Rs 450.23 crore in FY21, from Rs 301.87 crore in FY20, and its web revenue climbed 75 per cent to Rs 71 crore in FY 21, from Rs 39.6 crore in FY20.
In accordance with individuals accustomed to the matter, the corporate has finalized the plan to lift Rs 800-1,000 crore by way of an preliminary public provide (IPO) and is predicted to file its draft crimson herring prospectus (DRHP) with the markets regulator Sebi subsequent week.
The pandemic has compounded the state of affairs additional as firms internationally are in search of alternate provide options as they need to cut back dependence on China and develop both native provide chain or different chain.
In consequence, a number of Indian gamers witnessed order inflows from world chemical gamers to fulfill the availability disruptions from China.
Amongst the just lately listed specialty chemical substances firms, shares of Laxmi Organics, Rossari Biotech, Clear Science Applied sciences, Tatva Chintan and Ami Organics have given returns within the vary of 40 per cent to 200 per cent from their problem costs.
Related Articles
The post Aether Industries IPO: Specialty chemical firm Aether Industries plans to file up to Rs 1,000 crore IPO next week first appeared on StockMarket.